Tech Mahindra arm leverages AI for potential Covid-19 therapeutic drugs

Makers Lab does molecular docking studies of 19 FDA approved ligands and anti-virals. technique enables search for therapeutically potent drugs and molecules in real-time

IT services firm Tech Mahindra has said that the company's research and development arm Makers Lab, is taping into Artificial Intelligence (AI) to conduct research and find potential therapeutic drugs for the treatment of Covid-19. 

Makers Lab conducted molecular docking studies of 19 Food and Drug Administration approved ligands and anti-viral drugs. It is a technique that enables search for therapeutically potent drugs and molecules in real-time, to find compounds which can act as inhibitors against a viral protein computationally, according to the Pune-based company's statement.